Exchange: OTC·Updated 12:39 PM EDT

HRGN Biostage Inc

$2.15
$0.18
(9.14%)
Today
Reported EarningsMay 14
Mkt Cap$43.61M
Vol4.00

About HRGN

Harvard Apparatus Regenerative Technology, Inc. is a clinical-stage biotechnology company, which engages in the development of organ implants to treat congenital defects, cancers, and life-threatening conditions of the esophagus, bronchus and trachea. The company was founded by David Green on May 3, 2012 and is headquartered in Holliston, MA.
51

Neutral Sentiment

How do you feel about HRGN?

Advertisement|Remove ads.